ALEC - Alector, Inc.
IEX Last Trade
1.785
-0.005 -0.280%
Share volume: 17,786
Last Updated: Fri 27 Dec 2024 08:30:22 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.79
-0.01
-0.28%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-02-28 | 2023-05-04 | 2023-08-03 | 2023-11-07 | 2024-02-27 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 889.672 M | 837.038 M | 787.648 M | 748.342 M | 708.737 M | 672.395 M | 621.827 M | 635.494 M | |
| Current Assets | 827.021 M | 774.963 M | 726.435 M | 686.002 M | 647.992 M | 613.147 M | 565.807 M | 581.390 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 18.166 M | 16.657 M | 13.584 M | 16.673 M | 17.944 M | 24.286 M | 16.946 M | 19.307 M | |
| Short Term Investments | 18.166 M | 16.657 M | 13.584 M | 16.673 M | 17.944 M | 24.286 M | 16.946 M | 19.307 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 808.855 M | 758.306 M | 712.851 M | 669.329 M | 630.048 M | 588.861 M | 548.861 M | 562.083 M | |
| Total Non-current Assets | 62.651 M | 62.075 M | 61.213 M | 62.340 M | 60.745 M | 59.248 M | 56.020 M | 54.104 M | |
| Property Plant Equipment | 26.034 M | 26.289 M | 25.521 M | 24.998 M | 24.289 M | 23.115 M | 21.861 M | 20.835 M | |
| Other Assets | 35.145 M | 34.314 M | 34.220 M | 35.870 M | 34.907 M | 34.587 M | 32.613 M | 31.723 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 889.672 M | 837.038 M | 787.648 M | 748.342 M | 708.737 M | 672.395 M | 621.827 M | 635.494 M | |
| Total liabilities | 601.156 M | 583.934 M | 573.206 M | 565.327 M | 512.431 M | 509.840 M | 487.669 M | 456.587 M | |
| Total current liabilities | 149.409 M | 160.889 M | 93.809 M | 99.300 M | 132.270 M | 155.402 M | 177.948 M | 164.917 M | |
| Accounts Payable | 4.646 M | 4.546 M | 4.189 M | 3.126 M | 4.667 M | 4.679 M | 3.775 M | 4.586 M | |
| Other liabilities | 414.132 M | 386.590 M | 444.129 M | 431.977 M | 347.416 M | 322.595 M | 279.265 M | 262.648 M | |
| Current long term debt | 7.922 M | 7.990 M | 8.059 M | 8.130 M | 8.199 M | 8.390 M | 8.462 M | 8.535 M | |
| Long term debt | 37.615 M | 36.455 M | 35.268 M | 34.050 M | 32.745 M | 31.843 M | 30.456 M | 29.022 M | |
| Other liabilities | 414.132 M | 386.590 M | 444.129 M | 431.977 M | 347.416 M | 322.595 M | 279.265 M | 262.648 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 288.516 M | 253.104 M | 214.442 M | 183.015 M | 196.306 M | 162.555 M | 134.158 M | 178.907 M | |
| Common stock | 82.395 M | 82.603 M | 82.771 M | 83.102 M | 83.497 M | 83.928 M | 84.408 M | 93.810 M | |
| Retained earnings | -481.111 M | -527.259 M | -579.687 M | -625.544 M | -624.169 M | -668.644 M | -710.078 M | -746.157 M |